[Prediction and prevention of type 1 diabetes mellitus: initial results and recent prospects]

Orv Hetil. 2011 Nov 27;152(48):1916-21. doi: 10.1556/OH.2011.29246.
[Article in Hungarian]

Abstract

Epidemiological studies indicate that the incidence and prevalence of type 1 diabetes mellitus is rising worldwide. The increase in incidence has been most prominent in the youngest age group of childhood. Prediction of type 1a autoimmune diabetes can be established by a positive family history or by genetic, immunological or metabolic markers. Prevention of type 1 diabetes can be implemented at three different levels of pathogenesis: primary prevention in individuals without any sign of beta-cell damage, secondary prevention in individuals with signs of beta-cell destruction and tertiary prevention in patients with newly diagnosed type 1 diabetes. In recent years our knowledge of the disease pathogenesis has grown quickly, and several new prevention trials have been initiated worldwide. Immunologic intervention for type 1 diabetes will prove to be probably the most effective.

Publication types

  • English Abstract
  • Review

MeSH terms

  • Autoantibodies / blood*
  • Biomarkers / blood
  • Diabetes Mellitus, Type 1 / epidemiology
  • Diabetes Mellitus, Type 1 / etiology*
  • Diabetes Mellitus, Type 1 / genetics
  • Diabetes Mellitus, Type 1 / immunology
  • Diabetes Mellitus, Type 1 / metabolism
  • Diabetes Mellitus, Type 1 / prevention & control*
  • Diabetes Mellitus, Type 1 / virology
  • Enterovirus Infections / complications
  • Enterovirus Infections / prevention & control
  • Genetic Predisposition to Disease
  • Global Health
  • Glucose Tolerance Test
  • HLA-DQ Antigens
  • HLA-DR Antigens
  • Humans
  • Hypoglycemic Agents / administration & dosage
  • Immunosuppressive Agents / administration & dosage
  • Immunosuppressive Agents / adverse effects
  • Incidence
  • Insulin / administration & dosage
  • Insulin / genetics
  • Insulin-Secreting Cells / drug effects
  • Insulin-Secreting Cells / immunology
  • Insulin-Secreting Cells / metabolism*
  • Niacin / therapeutic use
  • Prediabetic State / diagnosis*
  • Prevalence
  • Primary Prevention / methods*
  • Secondary Prevention / methods*
  • Tertiary Prevention / methods*
  • Ultraviolet Rays
  • Vitamin D / administration & dosage
  • Vitamin D / immunology
  • World Health Organization

Substances

  • Autoantibodies
  • Biomarkers
  • HLA-DQ Antigens
  • HLA-DR Antigens
  • Hypoglycemic Agents
  • Immunosuppressive Agents
  • Insulin
  • Vitamin D
  • Niacin